Authors


Mark E. Larsen, DPhil

Latest:

Apps for Suicide Prevention: What the Research Says

A review of smartphone tools for suicide prevention and recommendations for clinicians.


Mark E. Servis, MD

Latest:

Drug Therapies for the Neurobehavioral Sequelae of Traumatic Brain Injury

Traumatic brain injury (TBI) is one of the most common causes of morbidity and mortality, especially in young adults. Recognition and early accurate diagnosis of neurobehavioral TBI sequelae are important in reducing the severity of postinjury symptoms. Sequelae of TBI include cognitive impairments, personality changes, aggression, impulsivity, apathy, anxiety, depression, mania, and psychosis.


Mark Eldaief, MD

Latest:

Advances in Neuroimaging: Impact on Psychiatric Practice

Neuroimaging is often used in clinical psychiatry to rule out medical and neurological conditions that can mimic psychiatric disease rather than for the diagnosis of specific psychiatric disorders.


Mark Frankel, MD

Latest:

Neuropsychiatry: Toward Solving the Mysteries That Animate Psychiatry

How do meaning, memory, emotions and, especially, human suffering arise from the brain?


Mark Green, MD

Latest:

The Truth About Marijuana

An interesting history, key myths, and the pros and cons of marijuana are explained in this book.


Mark H. Lewis, PhD

Latest:

Psychopharmacology of Autism Spectrum Disorders

Autism is a highly prevalent, highly heterogeneous disorder of unknown etiology. Studies to clearly establish the efficacy of various classes of psychoactive drugs are scarce. Nonetheless, available findings do support the efficacy of atypical antipsychotics and antidepressants in treating the core symptoms of repetitive behavior.


Mark Ilgen, PhD

Latest:

The Link Between Substance Abuse, Violence, and Suicide

Emerging research suggests that some individuals with particular types of substance use and abuse may be more likely to engage in suicidal behaviors. For example, those who use opiates, cocaine, or sedatives may have a noticeably higher risk of suicide than those who use other drugs.


Mark J. Albanese, MD

Latest:

SUBSTANCE ABUSE AND ADDICTION Advances and Challenges in Addiction Medicine

Recent years have witnessed exciting developments in understanding and treating addictions. For example, it seems that almost weekly we get new insights into the neurobiology underlying vulnerability to addiction. Similarly, there have never been more medications available to treat the spectrum of addictive disorders, especially alcohol, nicotine, and opioid dependence. In addition, studies continue to underscore the crucial role of psychosocial treatments in recovery from addiction.


Mark J. Goldblatt, MD

Latest:

Psychopharmacological Treatment to Reduce Suicide Risk

Adequate treatment of the underlying psychiatric illness consistently appears to be the most effective use of medication in suicidal patients.


Mark J. Niciu Jr, MD, PhD

Latest:

Alcohol Disorders: Practical Tips From New Research

In this review, we discuss the established medications as well as experimental therapeutic options that may emerge as future medications for alcohol intoxication, withdrawal, and/or long-term abstinence maintenance or harm-reduced drinking.


Mark L. Fuerst

Latest:

Brain Health in Aging Adults

Three studies highlight sedentary behavior and memory, cognitive decline in psychosis, and risk of dementia with anticholinergic drugs.


Mark L. Willenbring, MD

Latest:

Treating Co-Occurring Substance Use Disorders and Hepatitis C

Chronic infection with the hepatitis C virus (HCV) is frequently complicated by the presence of co-existing substance use disorders and mental illnesses. It is important to find improved ways to address barriers to care, and to provide effective and humane care to patients suffering from HCV infection.


Mark Messih, MD, MSc

Latest:

How About a Game of Chess?

A psychiatrist's chess game with his patient didn't go the way he expected.


Mark Newman, MD

Latest:

Psychiatric Emergency Strategies

Here we present how to assess safely patients who become oppositional or menacing in a clinic or office.


Mark Olfson, MD, MPH

Latest:

Psychiatric Ramifications of the COVID-19 Pandemic

Jeffrey A. Lieberman, MD, and Mark Olfson, MD, speak from the epicenter of the COVID-19 disaster, New York City.


Mark Olfson, MD, MPH

Latest:

Meeting the Mental Health Challenge of the COVID-19 Pandemic

The public is gripped by fear of COVID-19 and by worry over whether the health system will be able to treat them or their loved ones should they become ill. Consequently, clinical and public health efforts have focused on acute medical care needs of those who are severely affected, while containing the virus’s spread in the population.


Mark P. Bowes, PhD

Latest:

Research Review: Treating Major Depressive Disorder With MAOIs: Effect of Delivery System on Cardiovascular Events

Research Review: Treating Major Depressive Disorder With MAOIs: Effect of Delivery System on Cardiovascular Events


Mark R. Pressman, PhD

Latest:

Mini Quiz: Sleep and Violence

A quiz on complex sleep-related behaviors.


Mark S. Gold, MD

Latest:

Tipsheet: Physician Substance Abuse in the Workplace

Many barriers can prevent physicians who have a substance use disorder from obtaining the help they need. However, in many states, all is not lost for physicians who willingly participate in treatment. Here, signs, symptoms, and intervention steps.


Mark S. Komrad, MD, DFAPA

Latest:

Assisted Suicide Should Not Be Provided by Physicians: A Response to H. Steven Moffic, MD

The debate on physician-assisted suicide challenges medical ethics, emphasizing the role of doctors in providing care, not death, while navigating societal pressures.


Mark S. Micale, PhD

Latest:

The New Historical Trauma Studies

Recent decades have seen an outpouring of publications about psychological trauma. With its formal diagnostic category of posttraumatic stress disorder (PTSD), Western psychiatric medicine has led the way in opening up this field of study. Many other disciplines of inquiry, including sociology, anthropology, legal studies, and literary studies, also have contributed their distinctive approaches and methodologies to the subject. Most recently, professional historians in Britain, Germany, Austria, Australia, Canada, and the United States have researched the origins of PTSD to great effect. These “new historical trauma studies” draw heavily on pioneering medical research from earlier places and periods. In addition, empirical findings from and analytical insights into humanity’s troubled, traumatic past provide ideas, observations, and insights that may be useful for mental health practitioners today.


Mark Schultz, MD

Latest:

How Business Pressures Shape the Social Evolution of Modern Private Practice--A Case Study

All of the forces affecting and influencing my professional life thunder through my day like these footsteps on the bridge. So many times we hear that private practitioners are "dinosaurs" in today's managed health care environment. At times, I admit, I do feel like a hanger-on in some evolutionary cul-de-sac. Yet, as referrals keep coming in, I find myself feeling more and more fit to survive the Darwinian challenges facing psychiatry. Sharing daily life with colleagues I trust and respect better enables me to live with or ignore the "footsteps on the bridge," which in my more optimistic moments I imagine to be the sound of the real "dinosaurs" rumbling off into the mist.


Mark Shideler, MD

Latest:

Instrument Measures for Behavioral Symptoms in Patients With Dementia

Psychiatric disorders, such as primary sleep disturbances, depression, substance abuse, mania, sexually inappropriate behaviors, and psychosis, can complicate the care of patients with dementia.


Mark Vanelli, MD

Latest:

Improving Medication Adherence: How to Talk With Patients About Their Medications

Improving Medication Adherence: How to Talk with Patients About Their Medications, by Shawn Christopher Shea, is a slim and excellent primer on the verbal strategies and interviewing tips that clinicians can use to improve medication adherence.


Mark Zimmerman, MD

Latest:

Faith Is Not Enough: Self-Administered Questionnaire Screening for Bipolar Disorder

Bipolar disorder screening scales have modest sensitivity; thus, a negative result does not preclude a clinical evaluation.


Markus Heilig, MD

Latest:

The Changing Face of Alcoholism Treatment

At the core of alcoholism is the pathologically increased motivation to consume alcohol at the expense of natural rewards with disregard for adverse consequences. naltrexone and acamprosate represent the first generation of modern pharmacotherapies that target this pathology.


Marlene M. Maheu, PhD

Latest:

Telepsychiatry: The Perils of Using Skype

What Skype does not offer is a means of communication clearly suitable for clinical services-especially in mental health and psychiatry.


Marlene P. Freeman, MD

Latest:

Psychiatry and the Menopausal Transition: Clinical Caveats

The menopausal transition is characterized by sex hormone variability and a vulnerability to depressive symptoms and major depressive episodes. The rate of new-onset major depressive episodes is increased during the menopausal transition, as is the experience of depressive symptoms.


Marley A. Doyle, MD

Latest:

Inpatient Psychiatry: The Interpretation of Changing Scenery

Recently our inpatient psychiatric unit moved into a brand new facility. In the months and weeks preceding “the move,” there was much preparation and nervous energy. We had been preparing our patients and ourselves for this day. “


Marley Doyle, MD

Latest:

Utopia: The Transition From Inpatient to Outpatient Psychiatry

Outpatient psychiatry is a critical experience in becoming an independent psychiatrist.

© 2025 MJH Life Sciences

All rights reserved.